Abstract 5428
Background
The majority of gastric cancer-related studies include elderly patients. Studies have shown that gastric cancer carries more poor prognostic factors in younger patients.
Methods
In this study we retrospectively reviewed the results of gastric cancer patients under age 30 who had diagnosed and treated at our hospital. Statistical analysis of the study was done by the Kaplan-Meier test, Long Rank test and Cox regression analysis in the SPSS17 statistical program.
Results
824 patients had diagnosed with gastric cancer at our clinic. Of these, 30 (3.6%) patients were under 30 years of age. 17 of them were women (56.6%) and 13 of them were men (43.4%). Of these, the results of 22 patients, 9 males and 13 females, whose data were available, had evaluated. At the time of diagnosis, 5 patients (23%) were stage 2, 6 patients (27%) were stage 3, and 11 patients (50%) had metastatic disease. R0 resection was performed in 10 patients (90.9%) and R2 resection was performed in 1 patient (9.1%). Palliative surgery had performed in 4 (36.3%) of 11 metastatic patients. The tumor was grade 1 in 5,5% of patients, grade 2 in 16,6%, grade 3 in 77,8%. The tumor was diffuse type in 83.3% of patients and intestinal type in 16.6% of patients. The median follow-up was 11 months (2-101 months). Median progression free survival (PFS) was 3 months in metastatic patients, but median PFS was not achieved in non-metastatic patients. The 1 year PFS was 58% (p = 0.001) in non-metastatic patients (Figure 1A). Median overall survival (OS) was 6 months in metastatic patients, and median OS was not achieved in non-metastatic patients (p = 0.001). The estimated OS was 67 months in non-metastatic patients (Figure 1B). Tumor grade, histopathological subtype, presence of lymphovascular and perineural invasion and chemotherapy regimens were not correlated with PFS and OS. There was no correlation between OS and serum CEA, AFP, Ca19-9 and Ca125 levels at the time of diagnosis.
Conclusions
The ratio of gastric cancer under age 30 varies between 1-2% in the literature. In our study, the ratio of patients under 30 years old was 3.6%. Although young patients have more poor prognostic criteria such as diffuse type, proximal location, high grade, and lymphovascular invasion, the survival rates were similar to the elderly patients, according to the other studies in the literature.
Clinical trial identification
Legal entity responsible for the study
Cumhuriyet University Faculty of Medicine.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract